Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 59.31 | 76.65 | 21.20 | 10.71 | 5.35 |
Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 73.16 | 80.91 | 24.67 | 10.71 | 6.06 |
Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 50.04 | 78.06 | 24.02 | 7.01 | 7.01 |
Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 65.26 | 79.56 | 18.77 | 9.39 | 3.58 |
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 61.06 | 65.43 | 27.04 | 9.60 | 2.62 |
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 48.13 | 50.66 | 25.33 | 5.07 | 2.53 |
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 48.64 | 101.08 | 35.38 | 10.74 | 6.95 |
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 66.34 | 92.98 | 9.93 | 6.53 | 4.44 |
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 29.73 | 25.06 | 20.15 | 10.32 | 3.93 |
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 27.21 | 16.75 | 9.77 | 8.37 | 3.49 |
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 49.37 | 50.24 | 14.42 | 7.43 | 5.90 |
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 43.79 | 33.76 | 11.34 | 5.80 | 5.80 |
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 77.11 | 47.65 | 23.89 | 14.48 | 14.73 |
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 83.84 | 57.00 | 25.85 | 14.25 | 7.95 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 54.46 | 57.82 | 31.60 | 14.12 | 8.07 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 47.01 | 57.26 | 28.33 | 13.86 | 8.44 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 54.77 | 62.08 | 22.64 | 15.34 | 8.76 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 60.50 | 67.82 | 27.32 | 13.17 | 7.32 |
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 43.34 | 26.72 | 20.93 | 12.68 | 5.79 |
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 49.16 | 22.85 | 19.18 | 11.22 | 6.12 |
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 30.09 | 14.42 | 12.54 | 5.33 | 2.51 |
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 75.57 | 41.79 | 46.08 | 26.91 | 29.77 |
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 95.13 | 62.28 | 57.35 | 43.12 | 30.25 |
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 79.97 | 47.96 | 48.08 | 35.91 | 29.00 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 70.30 | 22.39 | 44.55 | 33.32 | 29.04 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 78.00 | 27.01 | 51.56 | 36.04 | 28.49 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 83.51 | 26.84 | 56.51 | 34.63 | 27.23 |
Basophils, donor1.CNhs12546.12241-129G9 | 26.75 | 28.72 | 12.19 | 8.65 | 10.23 |
Basophils, donor2.CNhs12563.12242-129H1 | 32.24 | 32.63 | 19.19 | 10.36 | 15.74 |
Basophils, donor3.CNhs12575.12243-129H2 | 38.55 | 27.71 | 9.91 | 10.22 | 15.33 |
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 64.36 | 27.58 | 37.70 | 37.70 | 11.95 |
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 56.93 | 37.95 | 43.07 | 32.23 | 14.46 |
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 54.72 | 29.58 | 17.38 | 23.29 | 14.05 |
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 77.78 | 42.22 | 42.99 | 14.72 | 27.66 |
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 57.01 | 28.15 | 67.25 | 24.45 | 21.61 |
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 44.33 | 41.98 | 40.52 | 22.90 | 57.55 |
CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 29.92 | 28.81 | 11.63 | 8.86 | 11.63 |
CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 38.91 | 29.88 | 13.24 | 11.63 | 21.26 |
CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 32.12 | 33.85 | 11.94 | 7.38 | 13.02 |
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 65.61 | 32.47 | 13.66 | 8.06 | 6.05 |
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 70.93 | 37.57 | 20.73 | 5.83 | 8.75 |
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 76.76 | 32.71 | 20.09 | 11.33 | 11.33 |
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 35.62 | 28.79 | 16.43 | 8.72 | 10.47 |
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 50.64 | 34.76 | 27.96 | 12.85 | 18.52 |
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 50.21 | 35.17 | 20.86 | 13.34 | 15.04 |
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 28.82 | 24.41 | 13.48 | 11.39 | 16.04 |
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 37.83 | 35.36 | 26.73 | 11.51 | 12.75 |
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 22.92 | 25.71 | 34.38 | 11.77 | 18.89 |
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 22.44 | 18.99 | 12.37 | 6.90 | 10.64 |
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 33.56 | 24.34 | 12.81 | 9.99 | 15.88 |
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 18.68 | 25.54 | 20.57 | 7.80 | 13.95 |
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 29.65 | 17.58 | 12.76 | 6.21 | 16.20 |
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 34.21 | 34.21 | 16.14 | 12.91 | 18.72 |
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 25.73 | 36.57 | 16.25 | 6.77 | 20.31 |
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 31.44 | 20.52 | 17.32 | 12.61 | 12.99 |
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 29.47 | 30.29 | 33.02 | 11.46 | 10.92 |
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 19.10 | 28.32 | 32.14 | 11.69 | 13.03 |
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 19.90 | 19.28 | 11.94 | 5.51 | 12.24 |
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 28.56 | 31.13 | 24.07 | 8.34 | 15.40 |
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 25.57 | 23.66 | 14.70 | 6.39 | 14.07 |
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 33.64 | 31.34 | 12.86 | 13.85 | 18.47 |
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 37.10 | 28.92 | 16.56 | 11.57 | 14.36 |
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 39.21 | 35.38 | 23.44 | 8.10 | 20.46 |
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 16.25 | 18.57 | 12.19 | 7.84 | 8.42 |
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 28.94 | 30.07 | 31.21 | 14.18 | 17.02 |
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 21.18 | 15.57 | 19.93 | 16.82 | 15.57 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 27.39 | 22.36 | 12.56 | 10.30 | 14.07 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 33.37 | 30.25 | 15.64 | 13.04 | 8.87 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 23.67 | 27.80 | 20.63 | 7.38 | 14.55 |
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 18.77 | 27.85 | 9.08 | 10.90 | 10.29 |
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 26.15 | 33.88 | 21.73 | 8.10 | 12.89 |
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 21.52 | 17.41 | 20.25 | 9.18 | 9.18 |
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 43.94 | 35.49 | 17.53 | 11.41 | 14.37 |
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 42.95 | 32.95 | 10.42 | 12.54 | 15.95 |
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 42.35 | 27.47 | 13.21 | 9.02 | 13.21 |
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 53.92 | 34.04 | 12.92 | 10.33 | 13.37 |
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 53.61 | 34.84 | 13.97 | 10.51 | 18.92 |
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 70.24 | 48.86 | 19.29 | 10.77 | 18.64 |
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 40.19 | 29.36 | 7.98 | 9.41 | 9.41 |
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 47.54 | 34.81 | 12.93 | 7.76 | 13.73 |
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 43.29 | 35.98 | 12.06 | 7.67 | 9.68 |
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 22.88 | 8.80 | 29.92 | 8.80 | 10.56 |
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 30.04 | 15.29 | 28.95 | 13.65 | 6.01 |
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 32.91 | 12.45 | 36.47 | 8.01 | 7.12 |
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 36.27 | 23.47 | 22.19 | 8.96 | 6.83 |
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 40.84 | 20.42 | 23.62 | 6.01 | 5.61 |
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 32.76 | 16.67 | 34.49 | 11.50 | 6.32 |
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 27.10 | 11.24 | 19.17 | 10.58 | 2.64 |
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 30.53 | 20.99 | 20.04 | 8.59 | 4.77 |
CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 29.03 | 24.48 | 35.29 | 25.05 | 7.40 |
CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 19.97 | 25.84 | 25.25 | 14.09 | 11.74 |
CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 24.08 | 21.41 | 34.02 | 19.50 | 10.32 |
CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 56.83 | 74.02 | 34.36 | 14.54 | 39.65 |
CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 35.87 | 38.11 | 29.15 | 21.86 | 29.71 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 52.68 | 42.67 | 40.82 | 22.65 | 27.39 |
CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 26.75 | 29.51 | 29.31 | 8.26 | 7.47 |
CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 25.15 | 31.05 | 24.76 | 9.43 | 8.25 |
CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 28.17 | 32.90 | 33.10 | 11.51 | 5.76 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 42.63 | 25.25 | 39.12 | 13.04 | 6.69 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 22.49 | 22.81 | 25.75 | 8.47 | 6.19 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 19.41 | 16.10 | 28.88 | 8.05 | 2.37 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 23.38 | 23.38 | 37.02 | 3.90 | 7.79 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 49.69 | 27.07 | 32.75 | 12.37 | 6.13 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 21.21 | 22.98 | 26.51 | 8.54 | 4.71 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 28.36 | 23.48 | 29.46 | 10.19 | 4.87 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 34.39 | 29.79 | 42.79 | 11.92 | 4.87 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 53.41 | 21.65 | 40.22 | 13.96 | 6.28 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 49.42 | 19.64 | 42.53 | 15.48 | 5.72 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 51.47 | 25.82 | 32.89 | 13.32 | 8.55 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 59.14 | 25.42 | 31.78 | 9.95 | 7.74 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 48.98 | 37.67 | 42.02 | 12.46 | 7.53 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 26.40 | 17.94 | 34.40 | 8.60 | 3.71 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 31.30 | 29.43 | 41.74 | 14.71 | 5.08 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 34.50 | 30.32 | 49.13 | 10.45 | 5.23 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 50.76 | 32.29 | 31.27 | 11.67 | 7.93 |
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 18.01 | 19.16 | 24.53 | 8.43 | 4.98 |
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 19.93 | 20.62 | 27.83 | 11.00 | 6.19 |
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 27.58 | 28.09 | 40.23 | 11.89 | 6.33 |
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 38.86 | 21.66 | 43.01 | 10.19 | 6.05 |
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 27.35 | 17.58 | 42.32 | 13.02 | 4.56 |
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 22.81 | 19.96 | 38.02 | 13.31 | 3.80 |
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 42.16 | 32.98 | 30.57 | 10.84 | 5.12 |
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 42.49 | 28.80 | 39.55 | 14.08 | 7.55 |
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 46.22 | 36.23 | 47.47 | 18.74 | 8.75 |
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 35.52 | 22.73 | 40.73 | 9.47 | 7.10 |
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 36.13 | 32.85 | 38.59 | 11.50 | 3.28 |
CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 19.76 | 31.45 | 26.61 | 10.08 | 5.85 |
CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 17.65 | 35.57 | 24.60 | 7.22 | 5.35 |
CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 25.49 | 32.15 | 27.95 | 10.57 | 6.52 |
Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 146.28 | 158.47 | 43.89 | 24.38 | 12.19 |
Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 49.63 | 52.99 | 36.22 | 15.43 | 26.83 |
Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 51.66 | 45.01 | 28.77 | 15.22 | 13.04 |
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 62.17 | 63.25 | 30.00 | 13.01 | 7.59 |
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 59.66 | 82.72 | 35.59 | 8.52 | 9.02 |
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 66.48 | 64.46 | 19.55 | 9.99 | 5.21 |
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 93.05 | 91.46 | 51.69 | 20.68 | 16.70 |
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 70.08 | 36.50 | 27.25 | 8.76 | 8.27 |
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 79.03 | 45.75 | 34.41 | 32.71 | 25.43 |
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 70.95 | 48.56 | 43.90 | 29.93 | 18.85 |
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 80.98 | 51.38 | 42.86 | 29.07 | 20.55 |
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 91.88 | 31.50 | 13.82 | 25.21 | 9.17 |
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 15.66 | 10.20 | 6.56 | 4.74 | 3.28 |
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 28.92 | 22.25 | 11.12 | 10.01 | 7.04 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 74.97 | 72.37 | 29.86 | 25.31 | 20.77 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3 | 81.67 | 76.09 | 30.47 | 31.52 | 19.50 |
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 72.20 | 60.63 | 24.73 | 24.73 | 19.68 |
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 43.88 | 56.52 | 20.51 | 15.26 | 9.30 |
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 38.32 | 65.21 | 22.88 | 17.16 | 11.44 |
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 34.17 | 82.09 | 23.77 | 21.17 | 9.66 |
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 64.60 | 60.03 | 42.73 | 36.57 | 16.89 |
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 62.80 | 46.45 | 49.03 | 28.39 | 14.62 |
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 61.10 | 61.44 | 40.96 | 28.47 | 16.32 |
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 98.36 | 79.14 | 62.75 | 48.05 | 18.66 |
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 37.75 | 44.05 | 28.53 | 20.56 | 7.97 |
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 52.00 | 48.97 | 40.17 | 34.39 | 15.96 |
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 75.66 | 57.68 | 53.71 | 40.96 | 18.60 |
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 65.38 | 53.23 | 38.25 | 25.58 | 11.63 |
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 68.66 | 65.82 | 47.67 | 30.60 | 10.67 |
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 89.04 | 67.28 | 48.53 | 30.46 | 13.72 |
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 54.78 | 49.15 | 28.60 | 17.32 | 11.68 |
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 51.70 | 53.98 | 41.81 | 28.13 | 12.92 |
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 72.73 | 45.64 | 19.28 | 18.30 | 11.47 |
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 55.15 | 60.30 | 45.22 | 36.03 | 14.71 |
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 44.56 | 50.23 | 34.84 | 22.68 | 9.72 |
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 63.13 | 43.31 | 44.29 | 38.40 | 29.92 |
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 71.18 | 47.38 | 32.78 | 28.74 | 43.78 |
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 71.51 | 49.66 | 39.98 | 39.98 | 39.64 |
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 73.59 | 58.26 | 24.53 | 24.53 | 21.46 |
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 56.96 | 55.06 | 56.01 | 34.17 | 13.29 |
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 67.24 | 45.25 | 37.37 | 31.88 | 14.66 |
Eosinophils, donor2.CNhs12548.12245-129H4 | 34.26 | 50.08 | 21.08 | 6.59 | 17.13 |
Eosinophils, donor3.CNhs12549.12246-129H5 | 27.14 | 50.41 | 19.39 | 7.76 | 7.76 |
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 15.70 | 13.96 | 9.59 | 2.62 | 3.92 |
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 64.11 | 64.11 | 20.38 | 6.46 | 4.97 |
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 65.72 | 64.71 | 25.20 | 17.98 | 11.78 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 71.24 | 97.98 | 46.08 | 24.23 | 8.74 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 88.06 | 90.07 | 47.33 | 16.92 | 9.75 |
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 73.42 | 67.74 | 29.08 | 17.38 | 7.80 |
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 59.43 | 68.96 | 37.00 | 22.99 | 6.73 |
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 66.18 | 84.33 | 49.10 | 20.28 | 8.54 |
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 40.21 | 46.37 | 19.24 | 9.87 | 4.44 |
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 92.43 | 102.39 | 35.79 | 23.96 | 15.25 |
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 74.09 | 54.83 | 26.94 | 23.84 | 11.45 |
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 70.45 | 53.94 | 33.18 | 26.97 | 14.88 |
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 57.21 | 58.12 | 21.49 | 10.75 | 3.48 |
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 80.66 | 74.90 | 30.54 | 16.13 | 14.40 |
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 28.12 | 20.39 | 17.11 | 7.97 | 6.80 |
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 55.56 | 64.62 | 27.16 | 21.54 | 9.05 |
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 81.01 | 74.16 | 43.93 | 34.23 | 14.26 |
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 48.27 | 41.70 | 35.72 | 21.97 | 10.01 |
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 79.74 | 39.58 | 34.88 | 33.00 | 26.89 |
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 81.58 | 40.63 | 46.94 | 40.79 | 28.17 |
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 74.02 | 45.93 | 48.46 | 34.97 | 23.60 |
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 90.64 | 67.58 | 34.30 | 22.25 | 10.00 |
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 68.66 | 42.38 | 36.48 | 26.78 | 18.55 |
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 101.26 | 72.33 | 24.80 | 17.15 | 13.64 |
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 86.72 | 62.96 | 26.14 | 13.07 | 8.32 |
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 93.47 | 79.13 | 24.73 | 15.08 | 8.41 |
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 39.14 | 48.24 | 14.56 | 8.19 | 2.73 |
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 20.84 | 17.97 | 10.78 | 2.87 | 2.87 |
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 74.57 | 47.13 | 35.01 | 31.31 | 24.41 |
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 95.72 | 52.93 | 38.54 | 34.16 | 29.15 |
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 103.07 | 97.53 | 47.66 | 27.98 | 16.07 |
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 84.72 | 86.04 | 26.34 | 10.54 | 15.80 |
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 74.17 | 72.33 | 17.78 | 12.87 | 7.97 |
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 96.75 | 76.17 | 27.94 | 11.12 | 6.01 |
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 47.30 | 41.97 | 31.53 | 18.26 | 12.14 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 108.17 | 118.40 | 54.36 | 22.24 | 11.66 |
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 61.72 | 74.53 | 27.12 | 10.89 | 5.13 |
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 63.37 | 72.90 | 34.54 | 18.23 | 9.75 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 97.83 | 96.33 | 53.72 | 23.11 | 9.90 |
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 57.81 | 75.13 | 28.44 | 17.73 | 9.38 |
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 104.09 | 110.27 | 40.96 | 14.94 | 4.64 |
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 74.63 | 73.33 | 23.26 | 9.12 | 5.03 |
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 93.84 | 93.50 | 52.15 | 22.11 | 8.61 |
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 73.27 | 80.78 | 23.68 | 14.52 | 8.28 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 109.56 | 96.43 | 62.10 | 26.51 | 13.63 |
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 64.43 | 61.49 | 36.08 | 17.03 | 10.40 |
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 70.48 | 80.98 | 30.39 | 15.36 | 6.95 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 117.51 | 118.22 | 47.57 | 19.88 | 9.59 |
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 58.74 | 75.16 | 24.89 | 17.73 | 9.57 |
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 73.42 | 77.49 | 35.10 | 15.77 | 9.33 |
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 59.91 | 61.26 | 37.69 | 30.54 | 14.30 |
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 59.19 | 41.46 | 31.64 | 27.27 | 8.18 |
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 74.00 | 60.23 | 41.01 | 36.42 | 17.78 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 42.45 | 37.32 | 64.89 | 60.26 | 14.88 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 56.86 | 40.42 | 71.17 | 75.81 | 23.86 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 46.94 | 31.26 | 61.35 | 57.86 | 21.15 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 51.31 | 45.71 | 38.67 | 50.79 | 26.85 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 51.47 | 32.80 | 58.54 | 48.19 | 18.92 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 58.76 | 36.86 | 82.12 | 68.25 | 23.72 |
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 64.14 | 76.66 | 31.29 | 14.08 | 3.13 |
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 83.62 | 75.90 | 26.37 | 12.22 | 2.57 |
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 88.41 | 67.69 | 30.39 | 16.58 | 4.14 |
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 65.01 | 65.01 | 25.08 | 11.14 | 9.29 |
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 45.48 | 58.47 | 11.55 | 10.11 | 10.83 |
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 58.21 | 57.85 | 37.86 | 29.22 | 8.87 |
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 64.23 | 82.10 | 52.77 | 34.56 | 11.13 |
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 62.66 | 85.80 | 56.64 | 34.95 | 10.60 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 56.69 | 55.92 | 38.82 | 30.11 | 8.82 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 70.59 | 69.29 | 49.89 | 33.55 | 8.93 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 70.71 | 73.79 | 60.03 | 35.59 | 11.86 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 50.97 | 63.51 | 38.97 | 28.04 | 8.36 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 66.52 | 81.82 | 52.00 | 32.77 | 8.05 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 58.48 | 81.18 | 51.94 | 30.01 | 10.00 |
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 51.67 | 33.22 | 23.62 | 14.02 | 9.60 |
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 23.84 | 16.83 | 12.62 | 0.00 | 5.61 |
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 40.75 | 21.81 | 17.29 | 7.00 | 3.29 |
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 19.11 | 29.40 | 17.64 | 1.47 | 1.47 |
Hepatocyte, donor1.CNhs12340.11523-119I2 | 39.29 | 41.83 | 6.34 | 11.41 | 2.54 |
Hepatocyte, donor2.CNhs12349.11603-120I1 | 28.50 | 27.52 | 29.48 | 17.69 | 2.95 |
Hepatocyte, donor3.CNhs12626.11684-122I1 | 41.36 | 35.45 | 15.95 | 11.23 | 5.91 |
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 67.10 | 54.74 | 64.90 | 30.90 | 6.18 |
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 42.92 | 54.24 | 50.92 | 36.40 | 11.44 |
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 51.47 | 33.11 | 49.75 | 26.42 | 13.21 |
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 63.22 | 53.78 | 39.29 | 24.91 | 9.88 |
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 38.22 | 25.85 | 15.74 | 19.11 | 13.49 |
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 46.04 | 34.18 | 21.41 | 24.43 | 16.99 |
Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 47.03 | 34.91 | 27.87 | 26.94 | 35.00 |
Keratocytes, donor1.CNhs11337.11527-119I6 | 21.83 | 11.08 | 14.99 | 8.15 | 6.19 |
Keratocytes, donor2.CNhs12095.11607-120I5 | 37.44 | 19.76 | 26.00 | 5.20 | 1.04 |
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 50.52 | 38.97 | 51.96 | 23.09 | 12.99 |
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 64.69 | 44.98 | 29.21 | 27.82 | 24.00 |
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 82.89 | 77.37 | 60.47 | 27.59 | 10.45 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 49.81 | 32.77 | 26.56 | 24.40 | 14.44 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 54.17 | 27.32 | 26.85 | 29.17 | 23.15 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 60.69 | 37.29 | 35.77 | 28.92 | 16.74 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 45.04 | 47.41 | 33.19 | 11.85 | 6.32 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 42.07 | 48.08 | 19.75 | 21.46 | 6.01 |
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 71.90 | 41.86 | 16.99 | 9.11 | 6.16 |
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 61.31 | 48.91 | 22.46 | 21.29 | 12.40 |
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 80.86 | 51.13 | 21.85 | 18.28 | 14.86 |
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 43.12 | 35.62 | 31.87 | 17.81 | 8.44 |
Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 62.83 | 64.67 | 25.53 | 14.95 | 12.26 |
Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 59.69 | 55.72 | 42.53 | 25.66 | 19.42 |
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 55.44 | 43.44 | 26.06 | 23.82 | 23.73 |
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 44.47 | 47.08 | 23.54 | 25.87 | 28.77 |
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 67.09 | 42.56 | 35.65 | 24.92 | 9.58 |
Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 47.79 | 30.05 | 65.52 | 69.96 | 33.50 |
Mast cell, donor1.CNhs12566.11563-120D6 | 54.59 | 26.24 | 23.69 | 13.65 | 21.13 |
Mast cell, donor2.CNhs12594.11565-120D8 | 48.51 | 23.84 | 19.28 | 10.16 | 16.59 |
Mast cell, donor3.CNhs12593.11566-120D9 | 54.91 | 29.69 | 26.09 | 17.58 | 19.46 |
Mast cell, donor4.CNhs12592.11567-120E1 | 53.53 | 26.51 | 22.09 | 11.49 | 23.61 |
Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 52.26 | 49.97 | 16.95 | 17.02 | 25.59 |
Melanocyte - light, donor1.CNhs11303.11274-116H5 | 61.12 | 56.53 | 16.43 | 12.61 | 14.90 |
Melanocyte - light, donor2.CNhs11383.11351-117H1 | 65.64 | 83.22 | 14.07 | 12.89 | 22.27 |
Melanocyte - light, donor3.CNhs12033.11423-118G1 | 65.01 | 49.61 | 20.53 | 13.69 | 18.82 |
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 38.77 | 42.67 | 21.90 | 25.40 | 18.82 |
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 47.45 | 44.45 | 18.92 | 30.94 | 18.32 |
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 52.31 | 57.74 | 20.29 | 20.01 | 20.01 |
Meningeal Cells, donor1.CNhs11320.11493-119E8 | 54.38 | 37.79 | 24.00 | 18.95 | 13.57 |
Meningeal Cells, donor2.CNhs12080.11573-120E7 | 63.65 | 45.34 | 30.08 | 28.34 | 12.21 |
Meningeal Cells, donor3.CNhs12731.11654-122E7 | 72.38 | 47.30 | 37.33 | 41.51 | 26.40 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 72.00 | 70.97 | 37.75 | 21.33 | 7.50 |
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 42.92 | 39.34 | 7.15 | 7.15 | 7.15 |
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 60.86 | 35.50 | 31.28 | 24.51 | 22.82 |
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 57.18 | 66.22 | 23.40 | 14.09 | 7.71 |
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 46.80 | 81.13 | 17.68 | 17.68 | 4.16 |
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 36.01 | 27.01 | 14.15 | 7.20 | 7.20 |
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 34.04 | 32.63 | 14.18 | 7.09 | 7.09 |
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 44.49 | 31.44 | 18.92 | 12.26 | 5.86 |
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 60.48 | 46.75 | 28.31 | 19.73 | 17.01 |
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 24.96 | 15.74 | 15.74 | 9.77 | 3.26 |
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 37.87 | 18.93 | 14.82 | 7.41 | 9.06 |
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 46.25 | 41.37 | 30.94 | 25.41 | 16.94 |
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 47.98 | 36.61 | 24.17 | 12.79 | 15.99 |
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 60.98 | 34.85 | 30.89 | 15.05 | 19.80 |
Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 61.80 | 58.18 | 28.03 | 12.06 | 4.22 |
Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 56.65 | 65.37 | 40.09 | 21.79 | 7.84 |
Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 63.98 | 56.88 | 31.39 | 15.60 | 5.70 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 70.54 | 40.14 | 17.03 | 15.81 | 10.95 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 70.32 | 59.77 | 19.59 | 6.53 | 4.52 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 69.58 | 52.71 | 10.54 | 12.65 | 4.22 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 59.19 | 82.43 | 23.24 | 10.06 | 4.31 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 63.17 | 109.12 | 22.97 | 10.34 | 8.04 |
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 82.73 | 96.99 | 38.51 | 15.69 | 42.79 |
Myoblast, donor1.CNhs10870.11241-116D8 | 71.67 | 61.10 | 35.76 | 24.76 | 10.42 |
Myoblast, donor2.CNhs11965.11322-117D8 | 86.92 | 80.14 | 44.38 | 24.25 | 10.27 |
Myoblast, donor3.CNhs11908.11398-118D3 | 95.44 | 78.43 | 34.74 | 17.19 | 5.01 |
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 54.14 | 35.64 | 36.65 | 15.80 | 11.88 |
Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 22.26 | 30.34 | 23.05 | 12.41 | 7.49 |
Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 21.99 | 36.87 | 24.80 | 9.92 | 7.98 |
Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 24.51 | 39.53 | 19.76 | 11.04 | 7.44 |
Neural stem cells, donor1.CNhs11063.11275-116H6 | 145.60 | 115.10 | 79.79 | 68.61 | 48.79 |
Neural stem cells, donor2.CNhs11384.11352-117H2 | 109.32 | 106.71 | 85.89 | 52.06 | 44.25 |
Neurons, donor1.CNhs12338.11494-119E9 | 55.68 | 51.81 | 47.17 | 30.16 | 24.75 |
Neurons, donor2.CNhs12726.11574-120E8 | 97.33 | 53.10 | 58.46 | 32.83 | 20.44 |
Neurons, donor3.CNhs13815.11655-122E8 | 62.52 | 42.74 | 44.02 | 33.81 | 17.86 |
Neutrophils, donor1.CNhs10862.11233-116C9 | 25.47 | 28.46 | 8.99 | 9.74 | 12.73 |
Neutrophils, donor2.CNhs11959.11314-117C9 | 44.87 | 14.96 | 14.96 | 11.97 | 2.99 |
Neutrophils, donor3.CNhs11905.11390-118C4 | 29.84 | 31.91 | 16.99 | 7.87 | 14.09 |
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 71.04 | 44.78 | 35.34 | 18.65 | 18.53 |
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 76.03 | 40.51 | 23.01 | 19.51 | 20.51 |
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 54.52 | 47.47 | 31.20 | 20.07 | 7.05 |
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 73.83 | 63.22 | 25.79 | 12.27 | 9.15 |
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 66.91 | 59.95 | 23.91 | 13.74 | 7.32 |
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 80.90 | 63.40 | 26.49 | 12.77 | 7.73 |
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 88.32 | 67.82 | 30.34 | 14.29 | 8.20 |
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 77.04 | 100.22 | 41.53 | 16.55 | 9.93 |
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 68.22 | 65.95 | 18.19 | 18.19 | 2.27 |
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 52.77 | 35.18 | 14.49 | 5.17 | 8.28 |
Osteoblast, donor2.CNhs11385.11354-117H4 | 71.74 | 88.34 | 55.79 | 24.58 | 13.95 |
Osteoblast, donor3.CNhs12036.11426-118G4 | 81.86 | 92.74 | 35.77 | 23.60 | 10.88 |
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 64.99 | 61.86 | 35.62 | 19.98 | 11.29 |
Pericytes, donor1.CNhs11317.11491-119E6 | 22.32 | 15.66 | 8.81 | 3.52 | 2.35 |
Pericytes, donor2.CNhs12079.11571-120E5 | 22.99 | 18.87 | 4.46 | 2.75 | 1.72 |
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 49.21 | 29.15 | 31.64 | 14.06 | 17.16 |
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 44.87 | 30.20 | 21.36 | 9.06 | 12.08 |
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 37.78 | 28.92 | 25.83 | 12.27 | 10.25 |
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 29.10 | 21.83 | 15.46 | 10.91 | 6.06 |
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 54.92 | 33.29 | 24.97 | 6.66 | 8.32 |
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 48.08 | 39.92 | 12.40 | 6.05 | 8.77 |
Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 72.70 | 67.98 | 34.74 | 7.20 | 5.21 |
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 101.90 | 94.99 | 49.57 | 17.96 | 10.13 |
Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 62.03 | 61.75 | 22.45 | 9.82 | 5.33 |
Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 74.19 | 63.04 | 24.60 | 11.40 | 5.25 |
Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 76.24 | 90.06 | 27.63 | 11.77 | 6.14 |
Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 64.82 | 62.89 | 24.45 | 11.90 | 5.15 |
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 40.07 | 50.46 | 19.29 | 5.94 | 2.97 |
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 72.17 | 60.14 | 39.63 | 30.23 | 20.51 |
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 52.74 | 53.45 | 27.88 | 17.05 | 5.68 |
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 82.21 | 79.09 | 52.56 | 30.14 | 15.69 |
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 86.72 | 64.91 | 47.77 | 27.52 | 11.94 |
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 66.94 | 62.75 | 38.70 | 24.17 | 14.06 |
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 43.39 | 53.42 | 53.30 | 46.77 | 10.64 |
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 63.96 | 60.95 | 37.90 | 31.28 | 10.63 |
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 54.51 | 36.37 | 23.66 | 19.89 | 10.77 |
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 56.83 | 45.81 | 40.41 | 29.85 | 15.84 |
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 34.23 | 32.23 | 19.67 | 14.39 | 6.56 |
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 65.30 | 58.87 | 24.78 | 13.37 | 5.90 |
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 21.66 | 17.15 | 13.54 | 6.32 | 7.22 |
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 62.46 | 41.97 | 27.80 | 22.18 | 18.33 |
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 25.10 | 18.82 | 14.90 | 8.63 | 7.06 |
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 24.84 | 20.46 | 19.00 | 4.38 | 5.85 |
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 65.44 | 44.54 | 37.68 | 23.85 | 18.58 |
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 45.49 | 13.65 | 14.79 | 7.96 | 1.14 |
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 48.99 | 24.32 | 23.47 | 19.73 | 9.01 |
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 61.75 | 54.19 | 38.43 | 22.24 | 18.14 |
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 38.56 | 26.22 | 20.05 | 6.17 | 4.63 |
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 27.09 | 17.61 | 17.88 | 10.30 | 3.25 |
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 21.07 | 11.04 | 15.05 | 5.52 | 5.52 |
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 42.82 | 26.76 | 19.63 | 10.96 | 7.65 |
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 32.41 | 23.27 | 12.47 | 4.16 | 4.16 |
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 36.94 | 19.03 | 16.57 | 9.40 | 5.60 |
Reticulocytes, biol_rep1.CNhs13552.11931-125I5 | 49.33 | 51.53 | 14.69 | 12.28 | 8.77 |
Reticulocytes, biol_rep2.CNhs13553.11932-125I6 | 49.15 | 38.43 | 14.64 | 12.55 | 7.32 |
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 58.98 | 48.73 | 35.39 | 29.75 | 22.31 |
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 48.55 | 27.55 | 34.11 | 16.07 | 5.58 |
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 67.03 | 42.30 | 46.20 | 34.82 | 27.98 |
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 45.85 | 37.09 | 18.44 | 13.29 | 6.70 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 78.48 | 51.83 | 45.88 | 27.29 | 12.09 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 70.79 | 48.60 | 54.29 | 27.64 | 9.98 |
Sebocyte, donor1.CNhs10847.11220-116B5 | 78.10 | 57.43 | 46.52 | 36.18 | 10.91 |
Sebocyte, donor2.CNhs11951.11301-117B5 | 63.71 | 41.60 | 31.20 | 21.45 | 7.15 |
Sertoli Cells, donor1.CNhs10851.11255-116F4 | 49.81 | 46.60 | 19.28 | 17.68 | 14.46 |
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 66.99 | 46.31 | 30.16 | 20.30 | 13.24 |
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 69.94 | 51.14 | 44.67 | 32.66 | 21.10 |
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 74.76 | 48.97 | 40.83 | 31.93 | 23.18 |
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 54.31 | 36.66 | 41.63 | 39.70 | 30.74 |
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 73.58 | 46.30 | 26.53 | 19.66 | 30.40 |
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 87.45 | 51.34 | 31.90 | 28.86 | 30.89 |
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 72.70 | 41.42 | 48.41 | 40.40 | 27.10 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 70.16 | 71.76 | 32.76 | 19.94 | 10.06 |
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 51.90 | 39.50 | 17.85 | 18.35 | 16.69 |
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 50.35 | 35.56 | 22.68 | 20.18 | 11.92 |
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 60.74 | 47.22 | 31.65 | 16.46 | 12.51 |
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 67.47 | 38.44 | 19.73 | 23.27 | 16.79 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 58.57 | 66.94 | 28.82 | 15.34 | 8.37 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 86.57 | 109.24 | 51.31 | 24.56 | 5.67 |
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 75.98 | 64.82 | 26.49 | 8.36 | 7.67 |
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 64.38 | 75.16 | 50.52 | 27.41 | 14.79 |
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 67.60 | 57.49 | 47.91 | 23.95 | 7.45 |
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 60.90 | 48.72 | 22.62 | 16.53 | 8.70 |
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 80.25 | 69.50 | 40.22 | 22.61 | 5.93 |
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 101.48 | 100.04 | 45.51 | 43.08 | 14.88 |
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 81.50 | 54.34 | 26.05 | 23.07 | 16.37 |
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 72.13 | 71.19 | 34.80 | 19.30 | 9.81 |
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 68.63 | 57.95 | 33.36 | 24.78 | 10.10 |
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 18.68 | 17.15 | 12.79 | 3.58 | 1.54 |
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 72.32 | 64.62 | 34.66 | 17.97 | 17.12 |
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 84.64 | 102.46 | 32.77 | 16.23 | 8.27 |
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 58.09 | 35.32 | 34.54 | 25.12 | 7.85 |
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 62.06 | 46.41 | 36.51 | 27.34 | 16.37 |
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 71.11 | 59.03 | 37.34 | 22.51 | 16.75 |
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 68.33 | 56.90 | 35.46 | 24.74 | 15.79 |
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 66.32 | 78.45 | 51.76 | 27.09 | 7.89 |
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 60.23 | 77.67 | 41.21 | 30.12 | 4.76 |
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 78.78 | 58.55 | 41.28 | 30.33 | 11.37 |
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 22.92 | 10.24 | 15.12 | 7.80 | 3.41 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 52.40 | 53.13 | 35.83 | 26.32 | 8.29 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 51.77 | 31.70 | 44.37 | 9.51 | 7.40 |
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 59.38 | 57.88 | 27.44 | 20.47 | 10.10 |
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 70.70 | 50.62 | 32.24 | 18.67 | 7.78 |
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 58.76 | 56.50 | 22.60 | 14.69 | 3.39 |
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 70.02 | 68.37 | 43.56 | 19.85 | 8.27 |
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 54.40 | 45.11 | 25.87 | 17.25 | 6.63 |
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 68.40 | 59.19 | 36.39 | 35.51 | 9.21 |
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 24.89 | 35.31 | 14.47 | 3.47 | 6.37 |
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 78.05 | 53.13 | 33.45 | 18.37 | 11.15 |
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 64.93 | 73.86 | 39.36 | 25.57 | 8.93 |
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 63.20 | 45.54 | 34.08 | 18.59 | 12.70 |
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 71.55 | 49.02 | 36.06 | 23.94 | 9.01 |
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 64.97 | 51.91 | 40.87 | 28.54 | 23.52 |
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 52.86 | 46.28 | 28.59 | 14.54 | 11.69 |
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 59.92 | 72.05 | 34.24 | 21.40 | 7.49 |
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 45.76 | 31.93 | 20.93 | 15.25 | 15.96 |
Synoviocyte, donor2.CNhs11992.11368-117I9 | 59.32 | 69.03 | 21.32 | 9.08 | 5.28 |
Synoviocyte, donor3.CNhs12050.11440-118H9 | 67.83 | 75.41 | 30.95 | 9.88 | 2.63 |
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 34.91 | 26.56 | 20.11 | 10.25 | 5.31 |
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 45.14 | 21.00 | 13.30 | 9.80 | 9.10 |
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 50.13 | 28.19 | 30.79 | 27.04 | 19.73 |
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 48.26 | 42.23 | 30.83 | 17.43 | 12.07 |
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 41.38 | 33.76 | 22.87 | 25.04 | 11.98 |
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 47.64 | 37.94 | 23.25 | 12.52 | 5.93 |
Urothelial Cells, donor1.CNhs11334.11520-119H8 | 17.65 | 21.09 | 15.93 | 6.89 | 0.86 |
Urothelial Cells, donor2.CNhs12091.11600-120H7 | 26.96 | 23.59 | 10.11 | 6.74 | 10.11 |
Urothelial Cells, donor3.CNhs12122.11681-122H7 | 24.83 | 17.74 | 13.75 | 5.32 | 3.10 |
Urothelial cells, donor0.CNhs10843.11216-116B1 | 45.49 | 38.82 | 26.19 | 21.36 | 16.54 |
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 39.58 | 22.33 | 22.84 | 10.15 | 3.04 |
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 30.59 | 16.06 | 19.12 | 6.12 | 3.06 |
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 43.29 | 18.80 | 21.65 | 9.11 | 4.56 |
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 40.74 | 21.44 | 20.96 | 6.19 | 8.10 |
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 42.37 | 21.80 | 25.92 | 10.70 | 8.64 |
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 36.96 | 21.40 | 22.70 | 7.78 | 2.59 |
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 28.62 | 18.36 | 22.68 | 5.40 | 6.48 |
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 42.83 | 18.24 | 26.97 | 7.14 | 6.35 |
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 70.29 | 50.96 | 41.77 | 33.01 | 13.14 |
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 88.55 | 39.46 | 28.87 | 20.21 | 5.77 |
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 159.28 | 106.10 | 81.60 | 61.26 | 35.53 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 57.23 | 22.67 | 50.35 | 22.67 | 32.14 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 54.25 | 32.32 | 51.50 | 31.02 | 19.19 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 67.87 | 35.64 | 82.03 | 31.73 | 19.49 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 51.02 | 40.18 | 90.55 | 33.00 | 10.20 |
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 58.08 | 43.91 | 54.09 | 45.90 | 41.51 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 42.32 | 32.75 | 40.79 | 22.98 | 18.58 |
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 68.79 | 39.58 | 59.90 | 42.33 | 53.55 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 80.18 | 79.53 | 60.38 | 30.19 | 20.45 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 62.62 | 45.49 | 58.97 | 24.99 | 17.41 |
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 66.42 | 54.09 | 44.73 | 30.81 | 33.32 |
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 81.47 | 35.25 | 67.84 | 51.55 | 55.15 |
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 92.73 | 32.58 | 67.67 | 20.05 | 40.10 |
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 51.97 | 37.07 | 63.99 | 27.76 | 15.24 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 68.25 | 66.48 | 63.27 | 30.35 | 29.71 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 96.06 | 61.95 | 72.04 | 32.69 | 21.19 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 69.41 | 66.43 | 47.69 | 26.83 | 36.62 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 87.59 | 52.21 | 29.88 | 8.59 | 12.02 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 82.03 | 71.59 | 53.15 | 55.92 | 33.80 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 99.98 | 72.92 | 47.42 | 55.25 | 28.85 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 95.77 | 64.07 | 50.39 | 51.39 | 32.87 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 71.32 | 58.42 | 51.19 | 30.09 | 28.33 |
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 104.96 | 95.21 | 38.98 | 30.62 | 35.91 |
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 66.47 | 50.47 | 30.77 | 23.39 | 35.70 |
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 36.24 | 31.64 | 35.16 | 19.20 | 11.63 |
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 80.94 | 44.63 | 54.29 | 34.97 | 104.58 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 36.66 | 35.25 | 35.25 | 16.92 | 29.61 |
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 55.39 | 43.04 | 18.53 | 9.73 | 6.36 |
adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 61.39 | 41.46 | 20.95 | 16.85 | 10.99 |
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 106.07 | 51.58 | 42.11 | 21.84 | 7.16 |
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 47.70 | 31.32 | 22.40 | 15.60 | 23.63 |
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 78.99 | 67.91 | 44.33 | 23.58 | 15.06 |
amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 41.78 | 35.81 | 9.07 | 8.36 | 9.55 |
amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 55.83 | 52.27 | 14.55 | 16.33 | 8.02 |
amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 36.55 | 39.32 | 6.14 | 7.06 | 7.68 |
amygdala - adult, donor10196.CNhs13793.10167-103B5 | 91.46 | 59.65 | 13.92 | 9.94 | 9.94 |
amygdala, adult, donor10252.CNhs12311.10151-102I7 | 83.28 | 44.17 | 12.24 | 6.89 | 6.33 |
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 62.78 | 38.18 | 23.82 | 18.59 | 16.25 |
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 43.01 | 27.03 | 38.56 | 26.20 | 20.44 |
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 71.36 | 63.55 | 35.47 | 32.94 | 27.45 |
aorta, adult, pool1.CNhs11760.10052-101G7 | 50.41 | 31.68 | 19.33 | 9.36 | 9.56 |
appendix, adult.CNhs12842.10189-103D9 | 50.28 | 37.57 | 36.47 | 14.92 | 9.95 |
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 67.77 | 31.24 | 55.68 | 33.76 | 20.41 |
astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 124.56 | 66.68 | 42.34 | 29.76 | 31.70 |
b cell line:RPMI1788.CNhs10744.10427-106D4 | 61.30 | 20.92 | 40.49 | 32.74 | 36.93 |
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 50.08 | 63.76 | 21.77 | 14.93 | 5.91 |
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 95.71 | 74.77 | 67.49 | 41.97 | 16.63 |
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 35.80 | 28.11 | 23.09 | 21.66 | 6.44 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 91.57 | 64.97 | 37.34 | 32.23 | 90.04 |
bladder, adult, pool1.CNhs10616.10011-101C2 | 45.97 | 32.95 | 21.90 | 18.45 | 15.49 |
blood, adult, pool1.CNhs11761.10053-101G8 | 40.71 | 14.37 | 19.16 | 4.79 | 9.58 |
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 86.69 | 130.03 | 28.90 | 13.34 | 10.00 |
brain, adult, donor1.CNhs11796.10084-102B3 | 97.90 | 30.05 | 12.60 | 10.66 | 5.82 |
brain, adult, pool1.CNhs10617.10012-101C3 | 91.38 | 43.23 | 4.82 | 9.09 | 7.98 |
brain, fetal, pool1.CNhs11797.10085-102B4 | 135.74 | 39.92 | 35.93 | 31.94 | 19.96 |
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 64.07 | 48.70 | 21.62 | 25.00 | 28.91 |
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 67.43 | 61.92 | 23.70 | 19.77 | 6.65 |
breast, adult, donor1.CNhs11792.10080-102A8 | 84.82 | 39.87 | 39.15 | 13.05 | 7.25 |
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 65.77 | 16.50 | 73.06 | 42.90 | 8.42 |
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 30.76 | 15.76 | 40.68 | 23.14 | 8.64 |
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 30.26 | 22.46 | 17.73 | 22.93 | 14.18 |
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 81.01 | 30.68 | 27.58 | 23.10 | 17.93 |
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 49.86 | 69.11 | 58.03 | 30.04 | 15.46 |
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 78.13 | 46.88 | 53.48 | 36.81 | 38.20 |
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 97.43 | 61.12 | 15.06 | 8.86 | 14.17 |
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 84.06 | 39.44 | 13.63 | 10.37 | 6.27 |
cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 93.07 | 38.15 | 6.10 | 4.58 | 4.58 |
cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 87.47 | 36.05 | 14.93 | 9.18 | 4.87 |
cerebellum, adult, pool1.CNhs11795.10083-102B2 | 95.76 | 26.30 | 8.87 | 6.21 | 7.09 |
cerebral meninges, adult.CNhs12840.10188-103D8 | 90.17 | 44.97 | 6.14 | 11.19 | 10.09 |
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 35.84 | 29.85 | 22.55 | 13.51 | 8.17 |
cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 37.23 | 50.89 | 37.92 | 23.14 | 9.48 |
cervix, adult, pool1.CNhs10618.10013-101C4 | 52.56 | 35.78 | 17.39 | 14.00 | 14.16 |
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 60.39 | 41.70 | 22.10 | 16.64 | 8.66 |
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 27.90 | 13.60 | 10.38 | 13.14 | 15.45 |
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 43.17 | 24.32 | 29.35 | 32.85 | 23.07 |
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 41.94 | 15.97 | 18.36 | 21.62 | 10.54 |
chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 33.50 | 31.26 | 12.44 | 9.89 | 8.29 |
chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 62.19 | 62.84 | 30.41 | 18.69 | 10.53 |
chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 40.51 | 37.85 | 18.66 | 12.26 | 8.00 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 45.99 | 73.58 | 62.34 | 21.46 | 7.15 |
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 54.32 | 41.44 | 43.95 | 25.90 | 27.47 |
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 94.91 | 43.71 | 52.02 | 39.23 | 62.16 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 68.13 | 37.67 | 50.08 | 47.60 | 41.06 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 75.09 | 39.21 | 61.76 | 49.60 | 36.66 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 78.37 | 40.11 | 60.92 | 45.31 | 38.43 |
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 63.57 | 43.26 | 46.68 | 50.66 | 27.89 |
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 120.31 | 59.92 | 65.48 | 41.80 | 40.69 |
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 43.04 | 20.68 | 25.11 | 25.32 | 16.46 |
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 39.18 | 29.71 | 49.30 | 28.24 | 12.41 |
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 42.55 | 36.05 | 61.49 | 25.30 | 6.08 |
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 70.76 | 29.43 | 67.08 | 64.70 | 36.35 |
colon, adult, donor1.CNhs11794.10082-102B1 | 58.72 | 44.79 | 20.90 | 8.96 | 6.97 |
colon, adult, pool1.CNhs10619.10014-101C5 | 47.77 | 47.06 | 16.54 | 12.38 | 11.50 |
colon, fetal, donor1.CNhs11780.10070-101I7 | 64.77 | 35.44 | 33.00 | 25.66 | 23.22 |
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 49.22 | 21.94 | 48.63 | 40.92 | 19.87 |
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 40.28 | 20.51 | 60.42 | 38.30 | 16.56 |
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 45.01 | 23.49 | 60.46 | 46.68 | 16.19 |
corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 68.48 | 56.82 | 9.30 | 9.77 | 7.55 |
diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 69.02 | 30.50 | 21.67 | 8.83 | 8.83 |
diencephalon, adult.CNhs12610.10193-103E4 | 87.61 | 67.70 | 7.26 | 8.20 | 11.24 |
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 48.90 | 25.73 | 67.51 | 30.47 | 31.93 |
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 72.20 | 51.85 | 50.09 | 48.52 | 24.46 |
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 48.80 | 55.84 | 29.86 | 37.15 | 25.49 |
ductus deferens, adult.CNhs12846.10196-103E7 | 64.32 | 50.90 | 14.21 | 7.50 | 6.71 |
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 75.01 | 45.98 | 30.25 | 20.57 | 10.89 |
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 104.06 | 43.16 | 37.65 | 26.93 | 22.65 |
dura mater, adult, donor1.CNhs10648.10041-101F5 | 54.34 | 39.49 | 16.11 | 14.15 | 16.74 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 46.45 | 29.91 | 23.30 | 36.83 | 65.39 |
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 73.31 | 41.06 | 45.83 | 50.91 | 27.17 |
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 35.23 | 18.61 | 21.93 | 21.93 | 12.63 |
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 39.39 | 25.16 | 22.18 | 27.47 | 8.61 |
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 41.44 | 21.35 | 18.52 | 20.41 | 8.79 |
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 41.82 | 29.87 | 29.87 | 19.12 | 17.92 |
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 33.01 | 19.07 | 33.87 | 24.19 | 5.12 |
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 66.84 | 35.36 | 28.71 | 18.86 | 5.55 |
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 53.11 | 50.68 | 30.55 | 16.84 | 6.25 |
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 43.80 | 51.25 | 34.89 | 43.12 | 63.40 |
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 52.06 | 57.89 | 82.27 | 56.24 | 23.94 |
epididymis, adult.CNhs12847.10197-103E8 | 66.22 | 42.98 | 13.10 | 14.33 | 8.74 |
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 90.12 | 52.28 | 21.33 | 17.54 | 8.60 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 87.37 | 84.57 | 72.18 | 41.99 | 9.87 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 82.59 | 63.81 | 51.60 | 34.06 | 10.09 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 88.27 | 87.12 | 74.97 | 44.10 | 11.00 |
esophagus, adult, pool1.CNhs10620.10015-101C6 | 42.58 | 43.16 | 15.91 | 11.06 | 12.22 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 49.95 | 28.51 | 34.24 | 36.27 | 20.30 |
eye, fetal, donor1.CNhs11762.10054-101G9 | 73.44 | 38.64 | 18.08 | 11.98 | 8.36 |
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 61.81 | 30.70 | 30.42 | 21.24 | 15.49 |
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 124.40 | 78.09 | 75.11 | 48.09 | 24.84 |
frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 94.52 | 40.96 | 6.65 | 6.77 | 5.51 |
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 55.73 | 66.68 | 40.28 | 36.37 | 10.95 |
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 46.81 | 35.67 | 20.52 | 23.09 | 13.31 |
gall bladder, adult.CNhs12848.10198-103E9 | 49.52 | 47.81 | 14.73 | 11.10 | 9.82 |
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 66.14 | 86.92 | 25.78 | 18.18 | 13.39 |
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 41.21 | 40.35 | 50.58 | 39.91 | 10.37 |
gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 76.28 | 47.76 | 50.97 | 26.34 | 11.80 |
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 46.67 | 49.93 | 38.61 | 25.40 | 11.50 |
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 50.13 | 23.48 | 47.25 | 25.21 | 5.33 |
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 82.01 | 51.07 | 59.02 | 44.48 | 37.15 |
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 52.80 | 44.31 | 35.59 | 16.03 | 9.19 |
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 87.25 | 84.40 | 71.62 | 39.41 | 14.68 |
glioblastoma cell line:A172.CNhs11185.10444-106F3 | 88.70 | 91.00 | 69.77 | 40.38 | 16.53 |
glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 75.07 | 50.39 | 39.78 | 31.72 | 23.15 |
glioma cell line:GI-1.CNhs10731.10413-106B8 | 54.03 | 48.25 | 34.10 | 23.69 | 15.31 |
globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 70.85 | 54.04 | 12.01 | 13.21 | 8.41 |
globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 61.06 | 47.64 | 10.95 | 7.53 | 6.43 |
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 72.82 | 106.03 | 63.87 | 74.09 | 149.46 |
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 67.04 | 61.89 | 29.22 | 19.77 | 12.03 |
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 56.52 | 26.29 | 44.95 | 26.81 | 23.66 |
heart - mitral valve, adult.CNhs12855.10205-103F7 | 60.32 | 44.69 | 16.76 | 14.24 | 8.38 |
heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 70.81 | 56.83 | 9.40 | 8.02 | 7.10 |
heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 41.64 | 35.18 | 61.02 | 30.15 | 17.95 |
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 49.12 | 30.95 | 7.19 | 5.59 | 3.59 |
heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 49.36 | 49.79 | 5.58 | 5.58 | 3.86 |
heart, adult, pool1.CNhs10621.10016-101C7 | 59.14 | 72.08 | 15.62 | 12.05 | 7.81 |
heart, fetal, pool1.CNhs10653.10046-101G1 | 55.70 | 40.98 | 14.65 | 14.04 | 10.08 |
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 58.01 | 53.68 | 23.78 | 12.25 | 7.93 |
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 33.78 | 44.27 | 18.64 | 30.29 | 40.77 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 65.07 | 55.31 | 45.85 | 37.26 | 20.33 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 66.76 | 57.28 | 46.48 | 42.94 | 19.29 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 65.79 | 58.37 | 51.29 | 41.52 | 21.16 |
hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 54.43 | 75.59 | 21.06 | 25.30 | 12.70 |
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 66.05 | 29.04 | 45.22 | 28.79 | 34.55 |
hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 78.73 | 46.12 | 14.31 | 14.31 | 8.75 |
hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 75.18 | 50.26 | 13.21 | 8.44 | 7.63 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 59.96 | 27.97 | 62.05 | 49.19 | 15.59 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 55.57 | 28.06 | 58.18 | 53.09 | 14.72 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 46.94 | 34.07 | 63.98 | 43.62 | 8.31 |
immature langerhans cells, donor1.CNhs13537.11904-125F5 | 33.52 | 59.39 | 16.65 | 18.90 | 53.54 |
immature langerhans cells, donor2.CNhs13480.11905-125F6 | 31.73 | 42.56 | 10.83 | 11.61 | 16.25 |
insula, adult, pool1.CNhs10646.10039-101F3 | 99.33 | 44.16 | 6.99 | 7.90 | 6.44 |
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 30.19 | 29.85 | 15.43 | 8.72 | 5.37 |
kidney, adult, pool1.CNhs10622.10017-101C8 | 50.12 | 41.92 | 15.92 | 10.72 | 6.86 |
kidney, fetal, pool1.CNhs10652.10045-101F9 | 56.34 | 38.29 | 33.15 | 18.62 | 12.33 |
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 64.73 | 50.79 | 71.07 | 36.54 | 18.48 |
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 33.53 | 25.64 | 20.44 | 24.74 | 10.04 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 30.90 | 22.65 | 18.42 | 17.85 | 21.49 |
left atrium, adult, donor1.CNhs11790.10079-102A7 | 70.75 | 55.75 | 11.44 | 12.15 | 7.15 |
left ventricle, adult, donor1.CNhs11789.10078-102A6 | 60.25 | 51.64 | 16.55 | 11.26 | 3.97 |
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 58.23 | 75.77 | 70.18 | 35.60 | 10.17 |
leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 57.01 | 49.96 | 21.72 | 14.66 | 10.32 |
leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 62.22 | 45.80 | 32.84 | 12.96 | 9.51 |
leiomyoma cell line:15425.CNhs11724.10571-108B4 | 61.40 | 55.85 | 32.66 | 16.66 | 10.78 |
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 52.68 | 64.65 | 29.93 | 13.17 | 7.18 |
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 29.31 | 23.56 | 43.92 | 29.64 | 38.58 |
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 57.59 | 59.64 | 17.04 | 11.08 | 4.26 |
liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 89.18 | 72.29 | 28.78 | 25.95 | 17.22 |
liver, adult, pool1.CNhs10624.10018-101C9 | 38.40 | 33.56 | 13.63 | 11.28 | 4.98 |
liver, fetal, pool1.CNhs11798.10086-102B5 | 38.43 | 22.53 | 18.55 | 11.93 | 13.25 |
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 76.28 | 42.02 | 9.44 | 11.51 | 14.22 |
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 54.61 | 39.01 | 11.64 | 8.99 | 7.67 |
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 61.42 | 35.59 | 24.98 | 16.08 | 8.73 |
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 66.25 | 71.19 | 85.28 | 35.24 | 20.44 |
lung, adult, pool1.CNhs10625.10019-101D1 | 55.00 | 33.00 | 21.57 | 15.48 | 13.46 |
lung, fetal, donor1.CNhs11680.10068-101I5 | 49.83 | 38.67 | 32.86 | 25.31 | 13.83 |
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 60.06 | 34.80 | 17.40 | 7.04 | 7.46 |
lymph node, adult, donor1.CNhs11788.10077-102A5 | 56.07 | 28.28 | 30.76 | 16.87 | 15.38 |
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 55.53 | 35.37 | 35.77 | 24.90 | 25.10 |
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 63.70 | 41.17 | 78.19 | 21.31 | 8.04 |
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 36.39 | 41.49 | 28.73 | 36.39 | 39.58 |
mature adipocyte, donor1.CNhs12558.12231-129F8 | 70.18 | 105.54 | 5.98 | 9.25 | 10.88 |
mature adipocyte, donor2.CNhs12559.12232-129F9 | 64.68 | 83.23 | 6.77 | 10.78 | 5.52 |
mature adipocyte, donor3.CNhs12560.12233-129G1 | 68.62 | 70.77 | 10.72 | 9.80 | 7.66 |
mature adipocyte, donor4.CNhs12562.12234-129G2 | 83.28 | 89.18 | 4.92 | 9.18 | 15.74 |
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 52.77 | 27.01 | 48.06 | 42.88 | 14.13 |
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 116.96 | 48.73 | 7.97 | 8.86 | 9.75 |
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 88.10 | 35.63 | 7.20 | 7.44 | 10.98 |
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 79.50 | 43.07 | 8.14 | 8.14 | 6.26 |
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 56.77 | 51.61 | 12.04 | 10.89 | 12.62 |
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 62.90 | 45.26 | 13.53 | 10.43 | 6.54 |
medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 67.25 | 51.23 | 11.80 | 9.44 | 9.31 |
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 73.74 | 93.39 | 49.11 | 46.49 | 30.30 |
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 89.99 | 61.49 | 37.99 | 43.24 | 39.87 |
melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 63.39 | 49.29 | 20.32 | 30.63 | 40.95 |
melanoma cell line:G-361.CNhs11254.10465-106H6 | 58.52 | 27.98 | 25.98 | 35.40 | 46.82 |
meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 51.76 | 31.29 | 20.23 | 23.76 | 18.82 |
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 81.02 | 48.24 | 29.04 | 30.91 | 18.73 |
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 83.62 | 56.81 | 54.49 | 41.01 | 13.19 |
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 56.27 | 51.19 | 32.84 | 21.19 | 8.36 |
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 50.01 | 46.51 | 19.87 | 16.13 | 11.92 |
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 56.59 | 77.12 | 43.27 | 23.86 | 6.66 |
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 68.19 | 68.94 | 24.81 | 12.12 | 4.74 |
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 57.86 | 68.68 | 23.40 | 10.57 | 6.29 |
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 82.75 | 88.98 | 36.48 | 17.80 | 5.34 |
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 40.28 | 32.72 | 18.99 | 8.47 | 5.26 |
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 49.30 | 58.53 | 33.72 | 13.91 | 5.60 |
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 58.60 | 52.85 | 29.69 | 16.17 | 5.44 |
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 62.25 | 49.68 | 31.20 | 22.03 | 9.31 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 53.84 | 38.23 | 45.56 | 23.10 | 6.05 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 64.32 | 40.93 | 20.24 | 9.45 | 7.65 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 60.71 | 44.25 | 29.66 | 17.39 | 6.06 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 62.21 | 64.69 | 32.76 | 17.83 | 11.61 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 40.14 | 41.74 | 22.33 | 14.89 | 9.57 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 62.61 | 50.09 | 44.35 | 17.74 | 8.87 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 47.93 | 32.00 | 21.04 | 12.32 | 3.91 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 47.22 | 70.07 | 36.18 | 18.66 | 9.14 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 74.05 | 72.83 | 58.18 | 39.06 | 12.61 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 56.55 | 45.10 | 23.28 | 15.46 | 5.09 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 51.99 | 33.73 | 24.81 | 11.60 | 5.26 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 59.40 | 44.55 | 25.99 | 10.67 | 6.03 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 51.75 | 63.70 | 41.00 | 27.07 | 9.55 |
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 82.81 | 62.40 | 41.20 | 24.40 | 14.40 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 74.52 | 83.10 | 24.04 | 9.96 | 7.21 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 89.24 | 77.12 | 21.22 | 11.79 | 4.71 |
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 103.47 | 131.23 | 34.07 | 20.19 | 15.14 |
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 42.38 | 24.66 | 30.24 | 38.33 | 10.98 |
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 48.46 | 43.96 | 43.10 | 46.32 | 27.88 |
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 27.14 | 19.57 | 17.75 | 23.75 | 16.44 |
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 89.55 | 55.54 | 58.04 | 42.39 | 17.23 |
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 76.63 | 68.30 | 34.03 | 24.31 | 13.20 |
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 55.80 | 53.84 | 26.92 | 25.70 | 33.77 |
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 54.08 | 70.56 | 41.91 | 25.97 | 11.10 |
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 30.88 | 27.17 | 25.63 | 16.06 | 5.25 |
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 49.34 | 45.61 | 36.84 | 25.66 | 22.15 |
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 77.39 | 78.10 | 52.83 | 40.46 | 27.39 |
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 52.86 | 50.93 | 31.64 | 33.57 | 22.96 |
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 79.40 | 52.20 | 59.81 | 30.07 | 15.37 |
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 53.55 | 38.69 | 47.92 | 21.52 | 11.02 |
mesothelioma cell line:No36.CNhs13074.10857-111G2 | 43.52 | 51.47 | 13.13 | 13.47 | 4.49 |
mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 64.72 | 62.29 | 66.24 | 41.63 | 13.07 |
middle temporal gyrus, donor10252.CNhs12316.10156-103A3 | 81.16 | 50.33 | 8.99 | 8.43 | 6.36 |
migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 69.76 | 53.39 | 59.63 | 27.48 | 15.39 |
migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 65.24 | 48.10 | 46.90 | 19.27 | 11.16 |
migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 70.66 | 46.94 | 31.73 | 13.25 | 15.21 |
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 85.83 | 39.31 | 17.36 | 22.93 | 16.05 |
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 53.33 | 17.70 | 22.86 | 17.45 | 14.75 |
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 52.62 | 42.47 | 30.64 | 20.71 | 29.58 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 38.40 | 24.00 | 47.20 | 27.80 | 16.20 |
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 61.13 | 39.05 | 37.13 | 24.86 | 21.45 |
myeloma cell line:PCM6.CNhs11258.10474-106I6 | 47.19 | 24.45 | 15.67 | 10.85 | 6.20 |
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 48.81 | 80.59 | 23.84 | 22.70 | 30.08 |
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 57.44 | 51.73 | 9.21 | 6.26 | 7.00 |
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 36.79 | 22.10 | 14.69 | 14.41 | 8.95 |
nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 30.48 | 27.99 | 15.55 | 31.73 | 21.15 |
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 64.08 | 45.91 | 51.80 | 52.05 | 44.51 |
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 63.62 | 56.39 | 56.50 | 31.27 | 23.51 |
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 61.02 | 97.35 | 52.53 | 60.23 | 21.39 |
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 55.48 | 51.11 | 48.93 | 55.26 | 46.85 |
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 70.27 | 90.47 | 42.09 | 36.66 | 21.05 |
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 124.99 | 194.51 | 76.10 | 70.15 | 55.48 |
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 108.69 | 286.66 | 66.06 | 89.73 | 40.40 |
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 118.99 | 158.66 | 82.12 | 63.13 | 28.49 |
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 75.05 | 61.69 | 32.75 | 13.99 | 15.26 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 88.72 | 22.32 | 55.20 | 60.96 | 158.43 |
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 32.82 | 40.03 | 16.01 | 31.22 | 19.21 |
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 54.66 | 57.49 | 16.93 | 14.81 | 4.23 |
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 70.13 | 59.41 | 26.34 | 16.54 | 17.15 |
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 91.98 | 47.02 | 8.61 | 8.29 | 5.07 |
occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 96.35 | 49.59 | 9.92 | 8.50 | 2.83 |
occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 74.23 | 39.75 | 8.94 | 8.46 | 7.02 |
occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 136.20 | 50.66 | 9.64 | 8.41 | 8.20 |
occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 147.97 | 42.35 | 60.50 | 37.05 | 24.45 |
occipital pole, adult, pool1.CNhs10643.10036-101E9 | 94.19 | 43.57 | 6.09 | 7.68 | 4.98 |
olfactory region, adult.CNhs12611.10195-103E6 | 89.13 | 49.09 | 6.78 | 7.59 | 7.91 |
optic nerve, donor1.CNhs13449.10277-104E7 | 119.93 | 61.39 | 7.14 | 8.57 | 8.57 |
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 41.32 | 30.92 | 42.89 | 24.64 | 4.32 |
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 36.33 | 37.87 | 50.26 | 34.68 | 11.80 |
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 96.48 | 82.18 | 72.27 | 40.90 | 18.89 |
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 39.86 | 24.26 | 47.94 | 24.14 | 12.25 |
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 110.98 | 91.91 | 17.54 | 8.01 | 3.43 |
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 36.59 | 37.28 | 34.52 | 73.18 | 82.84 |
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 25.46 | 31.43 | 13.13 | 12.73 | 10.74 |
ovary, adult, pool1.CNhs10626.10020-101D2 | 63.18 | 42.79 | 24.52 | 22.19 | 18.28 |
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 86.73 | 56.68 | 37.11 | 26.42 | 17.75 |
pancreas, adult, donor1.CNhs11756.10049-101G4 | 60.18 | 23.45 | 13.29 | 8.60 | 9.38 |
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 31.69 | 22.00 | 28.29 | 28.55 | 12.83 |
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 68.95 | 56.34 | 42.91 | 29.32 | 17.52 |
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 45.54 | 35.19 | 41.10 | 34.75 | 25.14 |
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 92.32 | 43.76 | 7.16 | 8.31 | 6.21 |
parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 78.89 | 43.74 | 7.81 | 7.81 | 3.12 |
parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 87.43 | 43.61 | 10.33 | 8.06 | 7.65 |
parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 93.47 | 43.76 | 6.66 | 6.91 | 6.09 |
parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 115.41 | 49.23 | 69.47 | 39.93 | 24.07 |
parotid gland, adult.CNhs12849.10199-103F1 | 77.85 | 46.05 | 8.22 | 3.29 | 8.22 |
penis, adult.CNhs12850.10200-103F2 | 54.58 | 45.16 | 11.91 | 11.41 | 8.44 |
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 36.58 | 45.37 | 16.53 | 39.40 | 23.04 |
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 243.39 | 168.90 | 137.60 | 77.68 | 43.95 |
pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 95.35 | 62.14 | 10.18 | 13.39 | 11.25 |
pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 81.38 | 71.96 | 16.14 | 9.75 | 8.07 |
pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 78.30 | 44.31 | 20.64 | 10.93 | 6.68 |
pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 64.43 | 45.08 | 30.05 | 9.56 | 4.55 |
placenta, adult, pool1.CNhs10627.10021-101D3 | 53.58 | 48.34 | 18.10 | 16.94 | 9.14 |
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 35.03 | 16.13 | 51.28 | 31.92 | 14.52 |
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 39.44 | 34.98 | 26.24 | 18.86 | 23.49 |
pons, adult, pool1.CNhs10640.10033-101E6 | 67.83 | 43.36 | 7.75 | 9.24 | 8.02 |
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 86.75 | 41.17 | 5.72 | 7.43 | 6.18 |
prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 35.93 | 25.53 | 37.47 | 18.20 | 4.25 |
prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 54.17 | 41.93 | 24.03 | 20.24 | 6.45 |
prostate, adult, pool1.CNhs10628.10022-101D4 | 52.98 | 41.44 | 22.53 | 13.27 | 10.13 |
putamen, adult, donor10196.CNhs12324.10176-103C5 | 106.05 | 39.28 | 11.16 | 7.07 | 5.18 |
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 25.22 | 22.98 | 44.00 | 36.44 | 25.50 |
rectum, fetal, donor1.CNhs11777.10067-101I4 | 84.92 | 35.61 | 42.92 | 29.22 | 33.79 |
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 48.58 | 31.09 | 42.97 | 19.43 | 6.48 |
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 29.14 | 5.73 | 17.68 | 44.43 | 27.71 |
retina, adult, pool1.CNhs10636.10030-101E3 | 57.47 | 42.46 | 10.65 | 9.43 | 6.65 |
retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 71.58 | 44.24 | 41.40 | 44.56 | 42.82 |
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 62.31 | 35.57 | 31.04 | 25.46 | 15.58 |
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 99.45 | 72.50 | 78.76 | 64.68 | 42.77 |
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 80.97 | 61.73 | 24.05 | 12.83 | 14.43 |
salivary acinar cells, donor1.CNhs12810.11771-123I7 | 54.08 | 57.81 | 31.08 | 37.30 | 18.24 |
salivary acinar cells, donor2.CNhs12811.11772-123I8 | 47.63 | 63.00 | 34.14 | 23.73 | 16.56 |
salivary acinar cells, donor3.CNhs12812.11773-123I9 | 32.49 | 57.37 | 22.12 | 21.43 | 19.36 |
salivary gland, adult, pool1.CNhs11677.10093-102C3 | 41.73 | 34.85 | 13.77 | 7.74 | 12.05 |
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 69.58 | 30.88 | 25.09 | 25.56 | 9.70 |
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1 | 83.42 | 33.06 | 34.26 | 31.70 | 14.40 |
seminal vesicle, adult.CNhs12851.10201-103F3 | 77.90 | 47.42 | 18.63 | 10.16 | 13.12 |
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 53.15 | 49.49 | 40.32 | 20.85 | 15.58 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 57.70 | 60.80 | 39.09 | 18.92 | 6.82 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 70.71 | 54.47 | 51.60 | 28.67 | 9.56 |
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 53.36 | 78.75 | 63.87 | 59.73 | 13.42 |
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 40.63 | 31.11 | 26.50 | 22.48 | 11.68 |
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 58.15 | 68.88 | 74.00 | 48.16 | 22.80 |
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 84.81 | 25.90 | 5.18 | 2.59 | 5.18 |
skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 61.80 | 32.03 | 7.70 | 8.11 | 4.72 |
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 85.83 | 48.71 | 30.16 | 27.84 | 33.63 |
skin, fetal, donor1.CNhs11774.10065-101I2 | 68.00 | 46.14 | 26.71 | 16.03 | 15.06 |
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 76.26 | 31.35 | 36.73 | 18.25 | 6.08 |
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 58.09 | 82.17 | 30.24 | 35.02 | 30.24 |
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 58.63 | 29.25 | 10.46 | 14.51 | 4.64 |
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 53.76 | 45.63 | 87.08 | 50.94 | 55.34 |
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 59.92 | 34.08 | 26.17 | 53.21 | 36.28 |
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 106.58 | 72.31 | 18.87 | 30.34 | 40.46 |
small intestine, adult, pool1.CNhs10630.10024-101D6 | 43.45 | 50.32 | 17.52 | 10.80 | 10.57 |
small intestine, fetal, donor1.CNhs11773.10064-101I1 | 58.57 | 39.34 | 31.25 | 19.89 | 16.83 |
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 34.33 | 32.45 | 23.05 | 23.52 | 19.28 |
smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 48.54 | 34.08 | 13.48 | 6.37 | 9.32 |
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 57.98 | 47.14 | 29.22 | 18.62 | 11.78 |
spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 73.42 | 42.21 | 12.96 | 10.01 | 16.10 |
spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 48.72 | 51.98 | 13.96 | 8.32 | 10.10 |
spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 70.58 | 32.97 | 19.02 | 14.79 | 13.95 |
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 78.85 | 62.19 | 25.32 | 13.59 | 11.22 |
spleen, adult, pool1.CNhs10631.10025-101D7 | 51.88 | 29.14 | 35.15 | 20.02 | 12.78 |
spleen, fetal, pool1.CNhs10651.10044-101F8 | 44.22 | 29.72 | 32.49 | 16.18 | 11.41 |
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 67.66 | 24.99 | 62.86 | 37.88 | 37.28 |
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 28.39 | 21.96 | 51.60 | 31.96 | 8.39 |
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 40.94 | 38.47 | 44.11 | 40.94 | 44.11 |
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 48.23 | 39.24 | 11.23 | 18.38 | 17.25 |
stomach, fetal, donor1.CNhs11771.10062-101H8 | 56.24 | 36.52 | 10.22 | 18.99 | 27.02 |
submaxillary gland, adult.CNhs12852.10202-103F4 | 57.80 | 40.37 | 15.60 | 7.34 | 6.42 |
substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 53.90 | 48.16 | 11.32 | 6.16 | 6.88 |
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 53.48 | 38.65 | 37.71 | 32.97 | 10.57 |
temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 83.36 | 39.98 | 7.62 | 8.23 | 5.58 |
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 104.72 | 37.09 | 35.34 | 22.25 | 23.13 |
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 67.72 | 51.84 | 31.74 | 12.70 | 10.58 |
tenocyte, donor1.CNhs12639.11763-123H8 | 71.80 | 87.05 | 34.60 | 11.90 | 6.70 |
tenocyte, donor2.CNhs12640.11765-123I1 | 60.55 | 64.24 | 19.87 | 12.02 | 8.78 |
tenocyte, donor3.CNhs12641.11768-123I4 | 60.57 | 79.17 | 33.31 | 9.95 | 5.19 |
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 46.81 | 26.12 | 28.01 | 35.83 | 20.19 |
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 82.82 | 31.80 | 44.91 | 67.31 | 32.78 |
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 50.30 | 35.35 | 30.79 | 20.78 | 13.94 |
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 67.52 | 33.76 | 26.01 | 33.15 | 21.62 |
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 56.12 | 20.84 | 26.45 | 25.12 | 40.62 |
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 34.00 | 21.23 | 19.76 | 30.78 | 36.57 |
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 74.96 | 16.55 | 35.60 | 46.13 | 38.86 |
testis, adult, pool1.CNhs10632.10026-101D8 | 173.15 | 37.89 | 23.95 | 48.65 | 11.75 |
testis, adult, pool2.CNhs12998.10096-102C6 | 244.65 | 40.73 | 30.28 | 59.76 | 13.93 |
thalamus - adult, donor10196.CNhs13794.10168-103B6 | 69.65 | 67.16 | 12.44 | 9.95 | 10.78 |
thalamus, adult, donor10252.CNhs12314.10154-103A1 | 63.92 | 49.96 | 12.10 | 8.90 | 6.62 |
throat, adult.CNhs12858.10209-103G2 | 46.27 | 46.27 | 14.07 | 11.94 | 7.89 |
throat, fetal, donor1.CNhs11770.10061-101H7 | 66.18 | 35.95 | 16.90 | 9.76 | 10.47 |
thymus, adult, pool1.CNhs10633.10027-101D9 | 85.45 | 49.93 | 61.49 | 24.67 | 9.82 |
thymus, fetal, pool1.CNhs10650.10043-101F7 | 67.23 | 40.41 | 42.65 | 16.08 | 8.75 |
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 48.78 | 34.20 | 26.46 | 32.63 | 43.51 |
thyroid, adult, pool1.CNhs10634.10028-101E1 | 53.02 | 34.18 | 19.60 | 9.42 | 7.32 |
thyroid, fetal, donor1.CNhs11769.10060-101H6 | 85.29 | 39.61 | 14.15 | 8.29 | 6.87 |
tongue, adult.CNhs12853.10203-103F5 | 50.73 | 55.30 | 12.19 | 11.10 | 7.18 |
tongue, fetal, donor1.CNhs11768.10059-101H5 | 62.63 | 41.41 | 14.72 | 8.56 | 6.84 |
tonsil, adult, pool1.CNhs10654.10047-101G2 | 45.80 | 32.87 | 24.65 | 14.21 | 8.35 |
trachea, adult, pool1.CNhs10635.10029-101E2 | 46.12 | 44.61 | 23.67 | 16.64 | 12.34 |
trachea, fetal, donor1.CNhs11766.10058-101H4 | 64.87 | 38.59 | 25.61 | 15.97 | 19.29 |
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 63.01 | 36.88 | 69.36 | 54.38 | 25.56 |
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 36.82 | 18.36 | 39.49 | 25.19 | 10.25 |
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 36.68 | 57.92 | 9.65 | 25.10 | 30.89 |
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 37.10 | 35.66 | 33.50 | 20.39 | 7.99 |
umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 51.62 | 23.46 | 9.39 | 4.69 | 7.04 |
uterus, adult, pool1.CNhs11676.10100-102D1 | 50.97 | 48.16 | 22.00 | 17.73 | 12.84 |
uterus, fetal, donor1.CNhs11763.10055-101H1 | 74.46 | 37.43 | 26.86 | 26.86 | 25.23 |
vagina, adult.CNhs12854.10204-103F6 | 51.93 | 37.95 | 43.27 | 11.32 | 7.32 |
vein, adult.CNhs12844.10191-103E2 | 57.77 | 30.39 | 29.18 | 13.49 | 11.47 |
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 51.93 | 26.93 | 42.32 | 21.48 | 24.68 |